Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
—
Company details
Market cap
$233B
P/E ratio
~28×
Div yield
~1.9%
Revenue
$44.3B
Net income
$6.5B
Profit margin
~15%
Rev. growth
+5.7%
Free cash flow
$7.4B
In plain English
Abbott is a broad healthcare company built on four legs: medical devices (its biggest engine, led by the FreeStyle Libre glucose sensor and the St. Jude heart-device business), diagnostics (the blood and rapid tests that power hospital labs), nutrition (Similac infant formula and Ensure adult shakes) and a generic-medicines arm for emerging markets. A 53-year-running dividend makes it a classic 'Dividend King'.
In simple terms
What Abbott Laboratories really sells
Abbott is a broad healthcare company built on four legs: medical devices (its biggest engine, led by the FreeStyle Libre glucose sensor and the St. Jude heart-device business), diagnostics (the blood and rapid tests that power hospital labs), nutrition (Similac infant formula and Ensure adult shakes) and a generic-medicines arm for emerging markets. A 53-year-running dividend makes it a classic 'Dividend King'.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.